欢迎光临金融市场技术研究院
微信公众号
投资群
读书群
文章
文章
报告
图书
公募
私募
资讯
搜 索
上传文档
首页
文章
报告
图书
公募
私募
资讯
金融终端
您的当前位置:
首页
>
研究报告
>
外盘报告
> 预览报告
收购诺华产品布局骨科领域,产品线逐步丰富
报告类型:港股公司研究
页数:4
文件大小:1.2M
上传时间:2024-09-22
机构:光大证券
作者:李君周
55阅读
0收藏
0下载
下载PDF
所需积分:1
如何获取K积分
下载PDF
下载全文所需积分:1
网友评论
{{Creator}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
{{Creator}}
:
回复
{{BeQuote}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
上传用户
文章
0
报告
0
图书
0
相关报告
Core Mengniu business better than expected, consolidated numbers dragged down by Yashili and Modern Dairy
Fuel price liberalization to take time; potential domestic M&A; project growth reiterated
1H 2016 Results in Line with Expectations. Maintain BUY
港股晨讯
每日晨讯
Earnings Growth Resumed in 1H16; Reiterate BUY
1H16 results in line; positive NIM migration offset by higher credit costs
1H 2016 Results Presentation Key Takeaway. Continues To Gain Market Share.
Increased concerns about execution ability; downgrade to UW
汇富快讯
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=5777486","PageTitle":"收购诺华产品布局骨科领域,产品线逐步丰富-外盘报告 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":74,"Face":"/_files/face/0/iueb7ftt.jpg","UName":"卿妙婧","UpArts":0,"UpRpts":24577,"UpLbies":28},"Rid":5777486,"IsPdf":true,"IsExist":true,"PdfUrl":"/download2.mtachn.com/upload/report/外盘报告/20160825-光大证券-泰凌医药-01011.HK-收购诺华产品布局骨科领域产品线逐步丰富.pdf","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}